Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Schenone

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Iscience|May 19, 2023
Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophreniaYu-Han H Hsu, Greta Pintacuda, Ruize Liu, et al.
Cancer Research|July 22, 2020
BRG1 Loss Predisposes Lung Cancers to Replicative Stress and ATR DependencyManav Gupta, Carla P Concepcion, Caroline G Fahey, et al.
Cancer Cell|June 15, 2021
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcomaBiniam Adane, Gabriela Alexe, Bo Kyung A Seong, et al.
Cell|July 1, 2017
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct MechanismsVictor Rusu, Eitan Hoch, Josep M Mercader, et al.
Science (New York, N.Y.)|April 25, 2024
Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cellsFabian Offensperger, Gary Tin, Miquel Duran-Frigola, et al.
Blood Cancer Discovery|January 11, 2022
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target GenesEva J Schaefer, Helen C Wang, Hannah Q Karp, et al.
Science Translational Medicine|April 1, 2021
Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitorBlandine Roux, Camille Vaganay, Jesse D Vargas, et al.
ACS Chemical Biology|October 19, 2018
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6William McCoull, Tony Cheung, Erica Anderson, et al.
Nature|April 12, 2019
WRN helicase is a synthetic lethal target in microsatellite unstable cancersEdmond M Chan, Tsukasa Shibue, James M McFarland, et al.
Blood Cancer Discovery|September 27, 2021
<i>ZBTB33</i> is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicingEllen M Beauchamp, Matthew Leventhal, Elsa Bernard, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Iscience|May 19, 2023
Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophreniaYu-Han H Hsu, Greta Pintacuda, Ruize Liu, et al.
Cancer Research|July 22, 2020
BRG1 Loss Predisposes Lung Cancers to Replicative Stress and ATR DependencyManav Gupta, Carla P Concepcion, Caroline G Fahey, et al.
Cancer Cell|June 15, 2021
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcomaBiniam Adane, Gabriela Alexe, Bo Kyung A Seong, et al.
Cell|July 1, 2017
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct MechanismsVictor Rusu, Eitan Hoch, Josep M Mercader, et al.
Science (New York, N.Y.)|April 25, 2024
Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cellsFabian Offensperger, Gary Tin, Miquel Duran-Frigola, et al.
Blood Cancer Discovery|January 11, 2022
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target GenesEva J Schaefer, Helen C Wang, Hannah Q Karp, et al.
Science Translational Medicine|April 1, 2021
Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitorBlandine Roux, Camille Vaganay, Jesse D Vargas, et al.
ACS Chemical Biology|October 19, 2018
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6William McCoull, Tony Cheung, Erica Anderson, et al.
Nature|April 12, 2019
WRN helicase is a synthetic lethal target in microsatellite unstable cancersEdmond M Chan, Tsukasa Shibue, James M McFarland, et al.
Blood Cancer Discovery|September 27, 2021
<i>ZBTB33</i> is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicingEllen M Beauchamp, Matthew Leventhal, Elsa Bernard, et al.
Pageof 6